Why carry out this study?

People living with type 2 diabetes (T2D) may require basal insulin (BI) therapy. Optimization of insulin management is an important aspect of glycemic control

Technological innovations such as smartphone applications are increasingly being used to support the optimization of BI titration; the My Dose Coach (MDC) smartphone app is designed to help users with T2D titrate their BI according to an individualized plan defined by their healthcare provider (HCP)

This study assessed the impact of frequency of MDC app use on achievement of relevant clinical outcomes (e.g., achievement of fasting blood glucose target [FBG])

What was learned from this study?

Almost half of MDC active users achieved their individualized FBG target, with greater frequency of MDC usage shown to be associated with positive FBG outcomes but not with any increase in hypoglycemia incidence

These results indicate that digital tools to support basal insulin titration could be useful to both people with diabetes and HCPs in diabetes management in terms of achieving better glycemic control with no increased risk of hypoglycemia